$CYCA Cytta and FIZUAS Form Strategic Partnership through

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
144
$CYCA Cytta and FIZUAS Form Strategic Partnership through VAR Agreement

Las Vegas, NV, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Lubbock, Texas and Las Vegas, Nevada, September 11, 2019 – Cytta Corp (OTCPINK:CYCA), the purveyor of the paradigm shifting SUPR™ compression technology, today announced a strategic partnership through a primary VAR Agreement with FIZUAS. FIZUAS (Flight Information Zone Unmanned Aerial Systems) is a trusted provider of remote UAS communication, information and IT solutions nationwide.

This partnership adds Cytta’s proprietary SUPR™ compression technology to FIZUAS’s extensive UAS remote communications systems integration capabilities. It enables FIZUAS to create proprietary solutions for traditional and beyond visual line of sight (BVLOS) systems by offering extreme high-resolution video/image delivery capabilities. By marketing and deploying Cytta SUPR™ compression solutions, FIZUAS is offering its customers a new and far more advanced information delivery strategy while drastically improving operations and efficiency.

This Agreement gives Cytta and FIZUAS a pivotal position in accelerating the provision of proprietary UAS communication solutions and professional services to Public Safety, First Responder, Energy, Agriculture and Oil and Gas customers. It also serves as a catalyst to driving new growth and market penetration of the nearly $50B market for information, surveillance, and security communications marketplace.

“Many of our customers are searching for new ways to increase their UAS utilization capability for their surveillance, information gathering and remote communications needs. Customers are looking to FIZUAS to not only better utilize information collected, but provide advanced technology paired, with AI, that provides better utilization of available network capability. The partnership with Cytta is a crucial step towards our objective of becoming the leading information collection and data utilization solutions provider,” said Mr. Christopher Camelio, Vice President, FIZUAS. “Cytta, their SUPR™ compression, and innovative technical integration team, are an ideal partner to help us fulfill our customers’ needs in today’s data and information focused world.”

“FIZUAS and their exceptionally talented team are a pioneering UAS operations and service provider. They bring a wealth of experience, credibility, and strategic thinking that complements our technology and our team. The relationship with FIZUAS represents a powerful opportunity for Cytta to significantly speed integration of our technology to multiple clients across the Security, Public Safety, Energy, Oil and Gas and Agriculture industries. FIZUAS’s focus on providing sUAS communication solutions to existing and new customers combined with our video/image compression technology, will allow the new team’s innovators to immediately serve a broad range of customers,” says Gary Campbell, CEO, Cytta Corp.

About Cytta Corp

Cytta Corp. is in the business of imagineering, developing and securing and marketing disruptive and paradigm shifting compression technologies. Cytta Corp. has created and is marketing the first miniaturized and productized version of a Video/Image Compression system integrating the SUPR™ compression technology. Cytta is now introducing Version 2 of the SUPRTech™ compression technology now combined with a revolutionary computer capability in its new series of operational systems. Cytta has commenced initial client deliveries of its integrated Version 2 SUPRTech™ system. Learn more at http://www.cytta.com.

About FIZUAS

FIZUAS (Flight Information Zone-Unmanned Aircraft Systems) is a full life-cycle drone and small Unmanned Aircraft Systems (sUAS) company, utilizing AI, in the security, public safety, energy, oil and gas and agriculture industries. sUAS programs have many benefits, ranging from increased safety, decreased costs, and improved efficiency. FIZUAS team members offer expert systems design, consultation, preventative maintenance programs, training, and education. FIZUAS offers both in-person and online consultation service with industry leading experts. From Oil & Gas Pipelines and Pads, Police, Fire and Safety, Energy Grid Infrastructure, and Agriculture, our industry solutions leverage the best technology, Artificial Intelligence (AI) and now best in class compression software solutions delivering startling results to your business. Learn more at http://www.FIZUAS.com

Cytta Corp.
Gary Campbell, CEO
Direct (702) 900 7022
Gary@cytta.com
http://www.Cytta.com

Michael Collins, Cytta Director Digital Media
Direct (310) 922-0478
MCollins@Cytta.com

Lee Skoblow, Cytta VP Investor Relations
Direct (925) 899 7930
leeskoblow@gmail.com

Corporate Communications Contacts:
Complete Advisory Partners
Office: (586) 228-2290
Cell: (586) 801-9002
Email: CapInc@comcast.net

Jerry Smith, President
Gateway Group, Inc.
425 922 7062
jlsmith@gatewaygroup.us
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

DXC Technology to Announce Q3 Fiscal 2026 Earnings Soon

Updated Category News Views 159

DXC Technology Announces Upcoming Q3 Fiscal 2026 Earnings DXC Technology (NYSE: DXC), a prominent leader in enterprise technology and innovation, has set a date for the release of its financial results for the third quarter of fiscal 2026. The earnings report will be published on a Thursday, after the market closes, providing stakeholders with insights into the company's...

Continue Reading
Jim Cramer Highlights Mettler-Toledo as a Buy Amid Market Woes

Updated Category News Views 188

Jim Cramer Recommends Mettler-Toledo International Inc. On a recent episode of CNBC's popular program, Jim Cramer advised investors to consider buying shares of Mettler-Toledo International Inc. (NYSE: MTD). Cramer's endorsement came after the company reported impressive quarterly results, showcasing strong financial health. Strong Earnings Report from Mettler-Toledo...

Continue Reading
Strategic Alliance Between Vireo and Curio Enhances Growth Opportunities

Updated Category News Views 110

Strategic Partnership Announced Leading cannabis companies Vireo Growth Inc. and Curio Wellness have forged a partnership aimed at leveraging shared resources to tap into the burgeoning cannabis market. This collaboration marks an exciting new chapter for both companies as they work to introduce innovative health and wellness products to consumers. Vireo Growth Inc.: A...

Continue Reading
Anoto Group Reports Second Quarter Results 2024

Updated Category News Views 137

Overview of the Interim Report for 2024 The interim report covering January to June 2024 provides important insights into Anoto Group AB's operations and financial health. Anoto Group continues to be a leader in technology, particularly in optical recognition and digital writing. This report emphasizes key financial metrics and the company's strategic initiatives in a...

Continue Reading
AAOS: Orthobiologics' Future Anchored in Solid Science

Updated Category News Views 9

The Challenge of Orthobiologics: Hype vs. Science Amid the buzz around orthobiologics, it's high time folks face reality: enthusiasm doesn't equal evidence. Dr. Jason Dragoo, the symposium co-chair, hit the nail right on the head—the medical community's chief duty is to sift the wheat from the chaff when it comes to flashy new treatments that lack scientific backing....

Continue Reading